Inotropic agents (%) | 45 | 55 | 0.80 |
Ventilation >24 h (%) | 4 | 7 | 0.68 |
Postoperative acidosis (%) | 25 | 33 | 0.87 |
Postoperative electrolytic disorders (%) | 25 | 67 | 0.009 |
Total CK (mg/dl) (mean (SD)) | 785.4 (35.)6 | 805.4 (28.6) | 0.97 |
MB-CK > normal range (%) | 8 | 0 | 0.80 |
Postoperative blood transfusion (%) | 20 | 25 | 0.95 |
Return to operating room (%) | 0.4 | 0 | 0.79 |
Cerebral implications (%) | 1.5 | 0 | 0.29 |
Pulmonary complications (%) | 1.5 | 0 | 0.29 |
Cardiac implications (%) | 3 | 0 | 0.63 |
Renal complications (%) | 1.5 | 2 | 0.20 |
Postoperative paroxysmal AF (%) | 23 | 25 | 0.96 |
Postoperative chronic AF (%) | 9 | 11 | 0.70 |
Postoperative adjunctive IV conduction disorders (%) | 7 | 11 | 0.84 |
Postoperative calcium antagonist (%) | 5 | 0 | 0.91 |
Postoperative β blockers (%) | 3.9 | 0 | 0.77 |
Postoperative nitrates (%) | 12 | 25 | 0.51 |
Postoperative ACE inhibitors (%) | 34 | 88 | 0.006 |